      Document 0042
 DOCN  DRG0042
 UNIQUE IDENTIFIER        DRG-0205
 NAME OF SUBSTANCE        Multivalent HIV-1 Peptide Immunogen [NIAID
                          VEU 017]
 PROTOCOL ID NUMBERS      NIAID VEU 017
 SECONDARY SOURCE ID      DRG
 PHARMACOLOGICAL ACTION   MODE OF ACTION: The antigenic principal
                          neutralizing determinant (PND) peptides are
                          the major immunogenic portion of this
                          multiple antigen peptide. [NIAID VEU 017]
 DISEASES STUDIED/TREATED Prevention of HIV infection [NIAID VEU 017]
 CLASSIFICATION CODE      Vaccine [NIAID VEU 017]
 CHEMICAL/PHYSICAL DATA   DRUG DESCRIPTION: Mixture of HIV-1 gp120
                          principal neutralizing domain (PND) branched
                          synthetic peptides from 15 viral strains
                          formulated in alum [NIAID VEU 017]
 CHEMICAL/PHYSICAL DATA   DRUG DESCRIPTION: Each strain component of
                          the vaccine consists of eight homologous
                          PND-derived peptides attached to a lysine
                          core to form radial-octamers [NIAID VEU 017]
 SUBSTANCE DELIVERY DATA  MODE OF DELIVERY: Intramuscular. [NIAID VEU
                          017]
 SUBSTANCE DELIVERY DATA  DOSAGE FORM: 0.5 ml vials. [NIAID VEU 017]
 SUBSTANCE DELIVERY DATA  STORAGE: Store vials at 2-8 C. Storage above
                          or below the recommended temperature may
                          reduce potency. Do not freeze since freezing
                          may destroy potency. [NIAID VEU 017]
 MANUFACTURERS            United Biomedical Inc
 ENTRY MONTH              9403
 LAST REVISION DATE       960310
 

SOURCE: National Library of Medicine, Bethesda, MD.  Distributed by AEGIS.
